|
|
||||||||
Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, Kodaira, Tokyo, Japan
Recent reports have shown that IL-17-producing CD4+ T cells (Th17 cells) belong to a distinct helper T cell lineage and are critically involved in the pathogenesis of autoimmune diseases and allergies. However, the chemokine receptor profile of Th17 cells remains to be clarified. In this study, we report that human Th17 cells are identified as CCR2+CCR5 memory CD4+ T cells. Analysis of PBMC from healthy donors showed that CCR2+ cells produce much larger amounts of IL-17 than CCR2 cells, indicating the preferential expression of CCR2 on Th17 cells. Notably, CCR2+CCR5 memory CD4+ T cells produced a large amount of IL-17 and little IFN-
, whereas CCR2+CCR5+ cells reciprocally produced an enormous amount of IFN-
but little IL-17. Moreover, a higher expression of T-bet was seen in the CCR5+ memory T cells. These results indicate that absence of CCR5 distinguishes human Th17 cells from Th1 cells.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society (S) to T.Y. and Grant-in-Aid for Young Scientists (Start-up) to T.A. for the Promotion of Science and Research Grants from the Ministry of Health, Labour and Welfare of Japan.
2 Address correspondence and reprint requests to Dr. Takashi Yamamura, Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan. E-mail address: yamamura{at}ncnp.go.jp
3 Abbreviations used in this paper: EAE, experimental autoimmune encephalomyelitis; DN, double negative; DP, double positive; SP, single positive; MFI, mean fluorescence intensity.
This article has been cited by other articles:
![]() |
A. Mildner, M. Mack, H. Schmidt, W. Bruck, M. Djukic, M. D. Zabel, A. Hille, J. Priller, and M. Prinz CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system Brain, September 1, 2009; 132(9): 2487 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Miossec, T. Korn, and V. K. Kuchroo Interleukin-17 and Type 17 Helper T Cells N. Engl. J. Med., August 27, 2009; 361(9): 888 - 898. [Full Text] [PDF] |
||||
![]() |
S Brand Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease Gut, August 1, 2009; 58(8): 1152 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nady, J. Ignatz-Hoover, and M. T. Shata Interleukin-12 Is the Optimum Cytokine To Expand Human Th17 Cells In Vitro Clin. Vaccine Immunol., June 1, 2009; 16(6): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Klemann, B. J.E. Raveney, A. K. Klemann, T. Ozawa, S. von Horsten, K. Shudo, S. Oki, and T. Yamamura Synthetic Retinoid AM80 Inhibits Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Am. J. Pathol., June 1, 2009; 174(6): 2234 - 2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rafei, P. M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, E. Birman, S. Yuan, Y. K. Young, M.-N. Boivin, K. Forner, et al. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner J. Immunol., May 15, 2009; 182(10): 5994 - 6002. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kondo, H. Takata, F. Matsuki, and M. Takiguchi Cutting Edge: Phenotypic Characterization and Differentiation of Human CD8+ T Cells Producing IL-17 J. Immunol., February 15, 2009; 182(4): 1794 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nowell, A. S. Williams, S. A. Carty, J. Scheller, A. J. Hayes, G. W. Jones, P. J. Richards, S. Slinn, M. Ernst, B. J. Jenkins, et al. Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis J. Immunol., January 1, 2009; 182(1): 613 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bosisio, M. Vulcano, A. Del Prete, M. Sironi, V. Salvi, L. Salogni, E. Riboldi, F. Leoni, C. A. Dinarello, G. Girolomoni, et al. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo J. Leukoc. Biol., December 1, 2008; 84(6): 1540 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Webb, A. Johnson, M. Fortunato, A. Platt, T. Crabbe, M. I. Christie, G. F. Watt, S. G. Ward, and L. A. Jopling Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists J. Leukoc. Biol., October 1, 2008; 84(4): 1202 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brenchley, M. Paiardini, K. S. Knox, A. I. Asher, B. Cervasi, T. E. Asher, P. Scheinberg, D. A. Price, C. A. Hage, L. M. Kholi, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections Blood, October 1, 2008; 112(7): 2826 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. P. M. Koenen, R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. H. Boots, and I. Joosten Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells Blood, September 15, 2008; 112(6): 2340 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. de Beaucoudrey, A. Puel, O. Filipe-Santos, A. Cobat, P. Ghandil, M. Chrabieh, J. Feinberg, H. von Bernuth, A. Samarina, L. Janniere, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells J. Exp. Med., July 7, 2008; 205(7): 1543 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamoto, M. Ogawa, Youwei Lin, M. Murata, S. Miyake, and T. Yamamura Review: Treatment of neuromyelitis optica: Current debate Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 43 - 52. [Abstract] [PDF] |
||||
![]() |
K. S. Sfanos, T. C. Bruno, C. H. Maris, L. Xu, C. J. Thoburn, A. M. DeMarzo, A. K. Meeker, W. B. Isaacs, and C. G. Drake Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing Clin. Cancer Res., June 1, 2008; 14(11): 3254 - 3261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Scriba, B. Kalsdorf, D.-A. Abrahams, F. Isaacs, J. Hofmeister, G. Black, H. Y. Hassan, R. J. Wilkinson, G. Walzl, S. J. Gelderbloem, et al. Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response J. Immunol., February 1, 2008; 180(3): 1962 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Lim, J. Lee, P. Hillsamer, and C. H. Kim Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells J. Immunol., January 1, 2008; 180(1): 122 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Singh, H. H. Zhang, J. F. Foley, M. N. Hedrick, and J. M. Farber Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6 J. Immunol., January 1, 2008; 180(1): 214 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Evans, T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes PNAS, October 23, 2007; 104(43): 17034 - 17039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Linden A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling Sci. Signal., August 7, 2007; 2007(398): re4 - re4. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |